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ABSTRACT

Acetyl-CoA carboxylase is an essential enzyme in all plants, animals and bacteria, where
it catalyzes the committed step in fatty acid synthesis. The Escherichia coli form of the enzyme
has three functional components that dissociate readily: biotin carboxylase, carboxyltransferase,
and a biotin carboxyl carrier protein. The biotin carboxylase component catalyzes the ATPdependent carboxylation of biotin, using bicarbonate as the carboxylate source. Biotin
carboxylase is a member of a functionally diverse superfamily of proteins known as the ATPgrasp enzymes. In the first study, four residues of biotin carboxylase, Lys 116, Lys 159, His 209
and Glu 276, were selected for site-directed mutagenesis based on their structural homology and
strict conservation among the ATP-grasp enzymes. The resulting mutants were subject to kinetic
characterization. The Km for ATP for all four mutants was significantly elevated relative to the
wild type enzyme, implicating the residues in binding ATP. The Vmax for the biotin-dependent
ATPase reaction was 30- to 260-fold lower than wild type, suggesting that the mutations have
misaligned the substrates for optimal catalysis.
In the second study, three more biotin carboxylase mutants were made based on their
homology to naturally occurring mutations of human biotin-dependent carboxylases. The three
mutations result in metabolic diseases, indicating that the residues involved are functionally
important. The mutants M169K, R338Q, and R338S were constructed and characterized. The
two Arg mutants displayed uncoupling of biotin carboxylation from ATP hydrolysis, suggesting
that the residue Arg 338 is important for aligning the carboxyphosphate intermediate for optimal
carboxyl transfer to biotin. Interestingly, all three mutants displayed negative cooperativity with
respect to bicarbonate, suggesting a communication between the two subunits of biotin
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carboxylase. Additionally, the level of residual biotin-dependent ATPase activity for M169K
and R338S was consistent with the severity of the phenotypes of the patients carrying the
corresponding mutations, thus establishing a molecular basis for the diseases.
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CHAPTER 1
INTRODUCTION

The Biotin-Dependent Enzymes
Biotin, or vitamin H, is an indispensable cofactor for a small number of enzymes that
catalyze the transfer of carboxyl groups. These enzymes participate in a variety of metabolic
functions, from gluconeogenesis to urea degradation to sodium transport. The biotin prosthetic
group, depicted in Figure 1.1, contains a ureido and a tetrahydrothiophene ring fused together
with a valeric acid side chain attached at the 2 position of the tetrahydrothiophene. The cofactor
is attached to the enzyme via an amide linkage between the valeric side chain and the ε-amino
group of a specific, highly conserved lysine residue. Biotin can be carboxylated at the 1’
nitrogen, thereby serving as the CO2 carrier for the enzyme.
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Figure 1.1
All of the reactions catalyzed by the biotin-dependent enzymes occur in two steps: the
first, in which biotin is carboxylated, and the second, in which the carboxyl group is relinquished
to an acceptor molecule. The enzymes are further categorized according to whether they
catalyze the fixation of CO2 (Class I), decarboxylation, releasing the CO2 as bicarbonate (Class
II), or the transfer of a carboxyl group from one molecule to another (Class III).
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Carboxylases (Class I). There are six Class I carboxylases (also called biotin-dependent
carboxylases), all of which use bicarbonate as the carboxylate source. The general reaction
catalyzed by the Class I enzymes is indicated in Scheme 1.1. The fixation of carbon requires
hydrolysis of one molecule of ATP, followed by the transfer of the carboxyl group to an acceptor
molecule.
E-biotin-CO2- + ADP + Pi

E-biotin + MgATP + HCO3-

acceptor-CO2- + E-biotin

E-biotin-CO2- + acceptor
Scheme 1.1

The biotin cofactor, covalently bound to the enzyme, is indicated as E-biotin. The six biotindependent carboxylases include pyruvate carboxylase, propionyl-CoA carboxylase, 3methylcrotonyl-CoA carboxylase, acetyl-CoA carboxylase, geranyl-CoA carboxylase, and urea
carboxylase. The first four biotin-dependent carboxylases are present in animals, where they
play important roles in gluconeogenesis, amino acid catabolism, and fatty acid biosynthesis,
respectively. Urea carboxylase has been characterized in yeast (1, 2), Chlamydomonas, and
Chlorella (3),where it allows the organism to utilize urea as a nitrogen source by degrading urea
to ammonia. Geranyl-CoA carboxylase, an enzyme previously thought to exist only in bacterial
systems, has recently been identified in plants (4), where it plays a role in isoprenoid catabolism.
Decarboxylases (Class II). The decarboxylases of Class II include oxaloacetate
decarboxylase, methylmalonyl-CoA decarboxylase, and glutaconyl-CoA decarboxylase. The
general reaction is indicated in Scheme 1.2. Note that the decarboxylases do not transfer the
carbon to an acceptor, but rather release it as bicarbonate. Generally, these enzymes are found in
the membranes of obligately anaerobic bacteria, where they harness the free energy of
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decarboxylation to transport sodium ions into the periplasm. The resulting electrochemical
gradient is then used to synthesize ATP (5).
E-biotin + R-CO2-

R-H + E-biotin-CO2-

E-biotin-CO2- + H+ + 2Na+intracellular

E-biotin + HCO3- + 2Na+extracellular
Scheme 1.2

Transcarboxylase (Class III). There is only one known transcarboxylase, which
catalyzes a carboxyl transfer from methylmalonyl-CoA to pyruvate. Transcarboxylase was
discovered in the bacterium Propionibacterium shermanii and is involved in the synthesis of
propionic acid from pyruvic acid (6). The two step reaction is indicated in Scheme 1.3.
E-biotin-CO2- + propionyl-CoA

E-biotin + methylmalonyl-CoA
E-biotin-CO2- + pyruvate

E-biotin + oxaloacetate
Scheme 1.3

Covalent Attachment of Biotin. The isolation of biocytin (ε-N-biotinyl-L-lysine) from
yeast extract was the first evidence that the attachment site on a biotin-dependent enzyme was a
lysine residue (7). This posttranslational modification is carried out by holocarboxylase synthase
(HCS), also known as biotin protein ligase (BPL). The site of covalent attachment contains the
nearly invariant tetrapeptide sequence Ala-Met-Lys-Met (8). Although it was once thought that
this region served as a recognition site for HCS, mutagenesis studies have indicated that the
methionines play a role in the carboxylation of biotin (9, 10).
Acetyl-CoA Carboxylase
The focus of this dissertation concerns the Class I enzyme acetyl-CoA carboxylase
(ACC), an essential enzyme found in all plants, animals, and bacteria (but absent from Archaea).
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ACC catalyzes the first and committed step in the de novo synthesis of long-chain fatty acids.
The enzyme was first discovered in 1958 when Wakil et al. observed that avidin, a protein that
irreversibly binds biotin, was inhibitory toward the carboxylation of acetyl-CoA (11).
The overall reaction catalyzed by ACC converts acetyl-CoA to malonyl-CoA in the
following two-step scheme:
E-biotin + MgATP + HCO3E-biotin-CO2- + acetyl-CoA

biotin carboxylase

E-biotin-CO2- + ADP + Pi

carboxytransferase

malonyl-CoA + E-biotin
Scheme 1.4

The two half-reactions occur at separate active sites on the enzyme. The first half-reaction is
catalyzed by the homodimeric biotin carboxylase component, while the second is catalyzed by
the heterodimeric carboxyltransferase component. The small biotin carboxyl carrier protein
(BCCP) contains the conserved lysine residue to which biotin is covalently attached. In bacterial
ACC, the two enzymatic components exist as separate proteins, whereas in eukaryotes,
presumably as a result of gene fusion, the functions are on a single multifunctional polypeptide
chain. A few bacterial species, such as Mycobacterium tuberculosis (12) and Myxococcus
xanthus (13), have the BCCP and biotin carboxylase components on the same polypeptide chain.
However, in the majority of bacterial systems, the BCCP is a separate subunit.
Regulatory Aspects of Acetyl-CoA Carboxylase
The essential activity of ACC is tightly regulated. The malonyl-CoA derived from ACC
is a substrate for the second enzyme in the fatty acid biosynthetic pathway: fatty acid synthase
(FAS). This enzyme is a multifunctional complex which, like ACC, is also found in all plants,
animals, and bacteria, including some Archaea. The acyl carrier protein (ACP) is the central
component of the complex which anchors the growing fatty acyl chain until it is released as
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palmitate (C16). Feedback inhibition by fatty acid synthase intermediates is an important
mechanism of ACC control (14, 15), however, a number of other regulatory mechanisms are
known.
Regulation in Prokaryotes. Davis and Cronan recently observed that E. coli ACC is
partially inhibited by acylated derivatives of ACP (16). Interestingly, the acyl chain length
carried by ACP was equally inhibitory between C6 and C20. Bacterial ACC is also regulated at
the transcriptional level. The transcription of E. coli ACC genes was shown to be closely related
to the rate of cell growth, which would be expected since fatty acids in bacteria are required only
for the synthesis of membrane lipids (17). Although the mechanism of transcriptional activation
of ACC is as yet unclear, James and Cronan recently reported that BCCP may have an
autoregulatory function ( *18 ). The accB and accC genes of E. coli, which encode BCCP and
biotin carboxylase, respectively, are cotranscribed as an operon (referred to as the accBC
operon). The carrier protein was found to inhibit transcription of accBC, suggesting a possible
feedback mechanism of transcriptional control. The unlinked accA and accD genes, which
encode the two subunits of carboxyltransferase, appear to be under a different set of
transcriptional controls (17, *18).
Regulation in Eukaryotes. Eukaryotic ACC has a more complex system of regulation
that includes assembly of the enzyme into active multimers or disassembly into inactive
protomers. Yeast ACC forms a tetramer in its active state and is regulated by a
phosphorylation/dephosphorylation cycle in which phosphorylation favors the inactive protomer.
The SNF1 gene in yeast encodes a 72 kDa protein kinase that has been shown to phosphorylate
ACC in vitro (19). An in vivo study (20) indicated that the SNF1 kinase causes inhibition of
ACC in yeast cells, and that the inhibition was due to a covelant modification (presumably
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phosphorylation). In animal tissues, active ACC polymerizes into long filaments (14), a state
which is activated by the Krebs cycle intermediates citrate and isocitrate. In this way, high levels
of citrate can signal a metabolic switch from fuel oxidation to fuel storage. On the other hand,
fatty acyl-CoA’s inhibit animal ACC, favoring the protomer state. Palmitoyl-CoA, stearoylCoA, and arachidyl-CoA are the most effective acyl-CoA inactivators of ACC (21).
Phosphorylation/dephosphorylation of ACC is also known to be a regulatory mechanism in
animal systems. Glucagon and epinephrine stimulate the phosphorylation of ACC, which
triggers disassembly of the filaments into inactive monomers, while insulin stimulates
dephosphorylation, reversing the inhibition (14).
Biomedical Relevance of Mammalian ACC Regulation. Two distinct isozymes of ACC
were discovered in human tissues: ACCA, which is cytoplasmic, and ACCB, which is localized
to the mitochondria. (22, 23). Interestingly, the expression of both isoforms of ACC, as well as
FAS, are upregulated in in situ breast carcinoma cells (tumor cells in a preinvasive stage of
progression) (24). Although the relationship between breast cancer and increased fatty acid
production is not very clear, increased flux through the fatty acid synthesis pathway could
presumably increase the production of certain signal-transducing lipids. A recently characterized
gene called BRCA1 encodes a 220-kDa protein believed to act as a tumor suppressor. The
BRCA1 protein has been shown to interact with numerous proteins involved in DNA damage
repair, cell cycle regulation, and tumor suppression (*25 ). In addition, Magnard et al.
demonstrated that the BRCA1 protein interacts specifically with ACCA, and that tumor-inducing
mutations in BRCA1 can disrupt this interaction (26). Thus, the ACCA/BRCA1 interaction can
be an indicator of tumor predisposition, and ACC is a potential target for anti-cancer theraputics.
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The isozymes of ACC have homologs in mice. The fact that there are two isozymes
presents the opportunity to study the suppression of ACC activity through gene knockout
experiments. A noteworthy study by Wakil et al. involving ACC2-/- mice demonstrated that the
mutant mice had lower body fat and decreased storage of glycogen and lipid droplets in the liver
compared to wild type mice, despite consuming 20-30% more food than wild type (27). This was
postulated to be a result of uncontrolled fatty acid oxidation due to decreased levels of malonylCoA (malonyl-CoA is a negative regulator of fatty acid oxidation). However, with respect to
growth rate, morphology, and breeding, the ACC2-deficient mice were normal. The ACC2
isozyme is thus a possible target for anti-obesity therapies as well if it can be inhibited
selectively over the ACC1 isozyme.
Recently, it was observed that leptin, a peptide hormone expressed in adipocytes,
suppresses the activity of ACC through the activation of a 5’-AMP-activated protein kinase (28).
Leptin secretion is associated with increased cellular energy expenditure and decreased hunger,
and because it is upregulated as adipocytes increase in size, it serves as a barometer for the cell’s
nutritional state. In fact, the increased feeding in the ACC2-deficient mice was attributed to a
decrease in leptin content in the plasma (27).
E. coli Acetyl-CoA Carboxylase – A Model System
A large portion of the current knowledge on the mechanism of biotin-dependent
carboxylases has derived from E. coli ACC. This enzyme provides an ideal model system for
enzymological study, primarily due to the fact that its three separate subunits are easily resolved,
and the two enzymatic components, biotin carboxylase and carboxytransferase, have been cloned
and overexpressed. Moreover, both subunits will use free biotin as a substrate, thereby
simplifying kinetic analyses.
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Perhaps the most valuable and informative aspect of the E. coli ACC model system is the
availability of structural information. In 1994, the crystal structure of the biotin carboxylase
subunit was solved to 2.4 Å resolution (29). The structure was later refined to 1.9 Å resolution
when the enzyme was cocrystallized with ATP, allowing many interactions between the
substrate and the active site residues to be discerned (30).
This dissertation will focus on the biotin carboxylase subunit of E. coli acetyl-CoA
carboxylase. The studies described herein take advantage of the wealth of structural information
on E. coli biotin carboxylase as well as the facile purification of the overexpressed protein.
Structural Aspects of E. coli Biotin Carboxylase. The original crystal structure of biotin
carboxylase revealed that the 449-amino acid protein contains three distinct structural domains.
The N-terminal domain has a dinucleotide binding motif with five parallel beta-strands. The
small central domain (called the “B-domain”), which protrudes conspicuously from the rest of
the enzyme, consists of two alpha-helices and three beta-strands which are attached to the protein
by a glycine-rich region. This region was not well defined in the crystal structure, suggesting it
may be flexible. In fact, the B-domain was postulated to close down over the active site upon the
binding of substrate. The C-terminal domain contains two antiparallel beta-sheets: one eightstranded and a smaller three-stranded sheet. There are also seven alpha helices in this domain.
The residues Arg 338, His 209, and Glu 276 were suggested to play important catalytic roles
based on their location in the active site pocket (29).
Soon after the the crystal structure of biotin carboxylase was solved, Artymiuk, et al.
noticed that biotin carboxylase had a strong structural homology with two other metabolically
unrelated enzymes: D-ala-D-ala ligase and glutathione synthetase. Artymiuk et al. (31) used a
program to compare the 3D coordinates of biotin carboxylase to those of other proteins cataloged
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in the Protein Data Bank. The folds of the three proteins were so strikingly similar that an
evolutionary relationship seemed certain. Interestingly, they share a sequence identity of only
11% (31), suggesting that evolution can preserve useful protein folds without conserving the
sequence. After the development of the PSI-BLAST (Position-Specific Iterative BLAST)
search, many more proteins with similar folds to that of biotin carboxylase were discovered and
included in a superfamily called the ATP-grasp enzymes (32). Included in the superfamily are
carbamyl phosphate synthetase, glycinamide ribonucleotide transformylase, and of course, all
biotin-dependent carboxylases. Not surprisingly, the ATP-grasp enzymes all catalyze reactions
with a similar chemistry, namely, the ATP-dependent ligation of a carboxylate-containing
substrate to an amine- or thiol-containing substrate. In addition, the ATP-grasp enzymes are
thought to activate their carboxyl substrates via the formation of acylphosphate intermediates
(32).
The subsequent crystal structure of biotin carboxylase with bound nucleotide revealed
that the B-domain does indeed close to cover the active site upon ATP binding (30). This
discovery is in good agreement with the structure of carbamyl phosphate synthetase, which was
cocrystallized with the nucleotide analog AMPPNP and revealed a similar closure (33).
Additionally, the closed conformation of the ATP-bound structure of biotin carboxylase brought
a number of residues into the active site pocket that had not been predicted from the unliganded
structure. Among these residues were Lys 116, Lys 159, and Met 169 (30). Moreover, sequence
alignments of ATP-grasp enzymes revealed that these three residues were highly conserved
throughout the superfamily (32).
Mechanistic Aspects of E. coli Biotin Carboxylase. Mechanistically, biotin carboxylase
(as well as the other biotin-dependent carboxylases) faces two problems with respect to carboxyl
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transfer to biotin: (1) bicarbonate is a poor electrophile and (2) the 1’ nitrogen of biotin is a poor
nucleophile. How can these two reactants be activated so that this chemistry is feasible? These
aspects of the catalytic mechanism have been extensively studied.
Activation of Bicarbonate. The currently accepted mechanism for activation of
bicarbonate is the formation of a carboxyphosphate intermediate, as shown in Scheme 1.5.
Carboxyphosphate is a highly unstable entity with an estimated half-life of 70 msec (34).
Since carboxyphosphate has never been isolated per se, a number of alternative
mechanisms have been proposed which did not involve the formation of carboxyphosphate. One
of the more well-known schemes was proposed by Calvin and Pon (35) and Lynen (36), in which
ATP reacts directly with biotin to form O-phosphobiotin. This intermediate then reacts with
bicarbonate to give N-1 carboxybiotin (Scheme 1.6).
O
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O- + ATP

HO

HO

O
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Evidence in support of the intermediacy of carboxyphosphate and against that of Ophosphobiotin derives from carbamyl phosphate synthetase because of its mechanistic homology
to the biotin-dependent carboxylases. Although this enzyme does not use the cofactor biotin, it
does catalyze an ATP-dependent carboxylation reaction for which the carbon source is
bicarbonate. Using a diazomethane quencher, Powers and Meister (37) successfully trapped
carboxyphosphate as a stable trimethyl ester from the reaction of carbamyl phosphate synthetase.
This experiment provided unambiguous proof of the phosphorylation of bicarbonate by ATP. It
would seem that that the biotin-dependent carboxylases follow a similar mechanism, although to
date, attempts to trap the intermediate in the same fashion from biotin carboxylase (38) and
pyruvate carboxylase (39) have been unsuccessful.
If carboxyphosphate cannot be trapped from a biotin-dependent carboxylase, isosteric
analogs of carboxyphosphate may provide further evidence of its intermediacy.
Phosphonoacetetic acid, a nonhydrolyzable analog, has been shown to inhibit pyruvate
carboxyase (40), though the Ki does not indicate a high affinity (0.5 mM). Polakis et al. (41)
discovered that biotin carboxylase catalyzes the phosphorylation of ADP by carbamyl phosphate
as follows [Scheme 1.7]:

H2N

O

O

C

P
O

O

-

O-

+

ADP

ATP

O

+

C
H2N

O-

Scheme 1.7
This scheme represents the reverse of the physiological reaction, with carbamyl phosphate acting
as an analog of carboxyphosphate. However, it can be easily argued that carbamyl phosphate
acts as an analog of O-phosphobiotin, particularly in light of the fact that biotin is not required
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for the ATP synthesis to proceed (42). Thus it seems that analogs provide tenuous support for
the existence of carboxyphosphate.
Climent & Rubio (43) observed that E. coli biotin carboxylase has a slow bicarbonatedependent ATPase activity in the absence of biotin, providing further evidence against the
formation of the O-phosphobiotin intermediate. Subsequently, it was demonstrated that when
ATP reacts with 18O-labeled bicarbonate, one of the labeled oxygens ends up in the product Pi
(38). These two observations have provided by far the most definitive evidence against the
requirement for biotin in the hydrolysis of ATP, which suggests that ATP reacts with bicarbonate
first to form carboxyphosphate.
The next question, and one which has no unequivocal answer as of yet, is the identity of
the carboxylating species. In other words, does biotin attack carboxyphosphate directly
(Pathway A of scheme 1.8), or does carboxyphosphate collapse into CO2 and Pi, with subsequent
attack on CO2 (Pathway B of scheme 1.8)? The advantage of the latter mechanism is that CO2 is
a much better electrophile than carboxyphosphate and the enzyme would thus be able to utilize
the abundant bicarbonate molecule to deliver a CO2 to biotin. This issue was addressed for
carbamyl phosphate synthetase by Gibson et al. (44) in an elegant experiment designed to
distinguish between an enzyme catalyzed dehydration of bicarbonate and a simple breakdown of
carboxyphosphate into bicarbonate and Pi. In pathway A, the rate of formation of ADP and the
proton should be equal because they are released simultaneously. This is due to the very short
half-life of the highly activated carboxyphosphate, which is rapidly hydrolyzed. If the enzyme
catalyzed the formation of CO2 from carboxyphosphate, as in pathway B, the rate of proton
release would lag behind ADP formation, indicating a slow, non-enzyme catalyzed hydration of
CO2. The rates of ADP and proton release were in fact, equal, which strongly supports
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carboxyphosphate as the carboxylating entity for carbamyl phosphate synthetase (44). In light of
the mechanistic homology of carbamyl phosphate synthetase with the biotin-dependent
carboxylases, it does not seem unreasonable to suppose that this mechanism also occurs in any
biotin-dependent carboxylase. Furthermore, several other enzymes of the ATP-grasp
superfamily proceed not through a carboxyphosphate intermediate, but through an acylphosphate
intermediate. Thus, direct attack on the acylphosphate would be the most plausible mechanism,
suggesting that the reaction catalyzed by biotin carboxylase proceeds analagously.
Activation of Biotin. The low nucleophilicity of biotin could be greatly improved by
deprotonation of the 1’ nitrogen, resulting in an enolate which could then attack the
carboxylating substrate. Possible mechanisms for 1’ deprotonation have been investigated. The
possibility that an active site cysteine and lysine could be an acid-base pair for removal of the
proton looked particularly attractive due to the work of Werneburg and Ash, who demonstrated
that O-phthalaldehyde inactivated pyruvate carboxylase (45). O-phthalaldehyde acts to crosslink lysine and cysteine residues, forming an inactive isoindole enzyme derivative. The
inactivation was blocked by the substrates, suggesting that the putative essential Cys-Lys pair
was located in the active site. The crystal structure of E. coli biotin carboxylase revealed that
Cys 230 and Lys 238 in the active site pocket were separated by 4.2 Å, a distance which would
permit the two residues to act as an ion pair and which would account for their cross-linkage by
O-phthalaldehyde. Furthermore, Cys 230 and Lys 238 are strictly conserved among the biotindependent carboxylases, supporting the notion that they could play this essential role. Thus, a
mechanism was proposed in which the ε-amino of Lys 238 deprotonates the sulfhydryl group of
Cys 230. The thiolate anion can then abstract the proton from the 1’ nitrogen of biotin while the
protonated lysine stabilizes the negative charge on the enolate oxygen (Scheme 1.9).
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Scheme 1.9
This mechanism was investigated by Levert et al. (42), who constructed the site-directed mutants
C230A and K238Q of biotin carboxylase. While kinetic studies on K238Q revealed that Lys 238
plays an essential role in the carboxylation of biotin, the kinetics of the C230A mutant resembled
wild type except for the elevated Km ATP, which implicated Cys 230 in binding ATP. Moreover,
the pKa of Lys 238 was found to be 9.4 or higher, making it an unlikely candidate for a catalytic
base. It was thus concluded that Cys 230 and Lys 238 do not act as an acid-base pair to activate
biotin, and that Lys 238 instead orients the carboxyphosphate intermediate for efficient carboxyl
transfer. To address the question of how the 1’ nitrogen is deprotonated, Levert et al. suggested
that one of the phosphate oxygens of carboxyphosphate could act in this capacity, an economical
mechanism known as substrate-assisted catalysis (42).
Objectives and Rationale for Study
While the chemical and mechanistic aspects of biotin carboxylase have been scrutinized
thoroughly, precious little information is available on the roles of the active site residues. A
more complete understanding of the catalytic mechanism would be gained through examination
of the interactions between key amino acid residues and the substrates they contact. To this end,
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site-directed mutagenesis was employed in two separate studies to explore the roles of the
residues Arg 338, His 209, Glu 276, Met 169, Lys 159, and Lys 116.
To approach these studies, the first question that must be asked is, “What residues do you
mutate?” and then “What do you mutate them to?” In the first study, the residues Lys 116, Lys
159, His 209 and Glu 276 were examined because of their high degree of conservation among
the ATP-grasp enzymes. Moreover, structural data on several ATP-grasp enzymes suggested
pertinent roles for the four residues based on their interactions with ATP. Thus, the residues
were each mutated to an isosteric residue or alanine in order to minimize disruption of the
protein structure. In the second study, Met 169 and Arg 338 were selected for mutagenesis due
to their involvement in two human metabolic diseases caused by deficiencies in biotin-dependent
carboxylases. In order to mimic the missense mutations that give rise to the disease states, the
same (homologous) mutations were introduced into the E. coli biotin carboxylase model system.
Thus, naturally occurring deleterious mutations provided the residue of interest as well as the
residue change.
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CHAPTER 2
SITE-DIRECTED MUTAGENESIS OF ATP BINDING RESIDUES OF E. COLI BIOTIN
CARBOXYLASE: INSIGHT INTO THE MECHANISM OF CATALYSIS*

Introduction
Acetyl-CoA carboxylase catalyzes the first committed step in long-chain fatty
acid synthesis, namely the formation of malonyl-CoA from acetyl-CoA, MgATP, and
bicarbonate. Found in all plants, animals, and bacteria, this enzyme is biotin dependent, with the
following 2-step reaction mechanism (Scheme 2.1):
E-biotin + MgATP + HCO3

-

E-biotin-CO2- + acetyl-CoA

Mg2+
biotin carboxylase

E-biotin-CO2- + ADP + Pi
malonyl-CoA + E-biotin

carboxytransferase

Scheme 2.1
The Escherichia coli form of this enzyme consists of three separable components. The biotin
carboxylase component catalyzes the first half reaction which involves the phosphorylation of
bicarbonate to form a carboxyphosphate intermediate, followed by the transfer of the carboxyl
group to the 1’ nitrogen of biotin (2). The carboxyltransferase component catalyzes the second
half reaction. In vivo, the biotin molecule is linked to the biotin carboxyl carrier protein through
an amide bond to a specific lysine residue. Both biotin carboxylase and carboxyltransferase
retain activity in the absence of the other two components and will also use free biotin as a
substrate (3). The crystal structure of the biotin carboxylase component has been solved and is
the only three-dimensional structure of a biotin-dependent carboxylase, making it the paradigm
for structure-function analysis of this class of enzymes (4).

Reprinted with permission from The Journal of Biological Chemistry. Copyright 2001, American Society of Biochemistry and
Molecular Biology.
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Two years after the solution of the crystal structure, Artymiuk et al. observed that biotin
carboxylase had a strong structural homology to glutathione synthetase and D-ala D-ala ligase
(5). Despite the remarkable similarity in the three-dimensional structures of biotin carboxylase,
D-ala D-ala ligase and glutathione synthetase, there is only an 11% primary sequence identity
between the three enzymes (5). Although biotin carboxylase is metabolically unrelated to these
two enzymes, all three enzymes are mechanistically homologous in that they catalyze the ATPdependent ligation of a carboxylate-containing substrate to an amine-containing substrate via
formation of an acylphosphate intermediate (5, 6). Structural similarity between the three
enzymes includes a common three-domain architecture in which the flexible central domain
extends away from the main body of the protein. The crystal structure of biotin carboxylase was
originally determined in the absence of any ligands or substrate analogs (4), and its central
domain (known as the B-domain) was in the “open” conformation, extending far out from the
main body of the enzyme. In contrast, the structures of D-ala D-ala ligase and glutathione
synthetase were solved in the presence of ADP and ATP, respectively, which revealed that the
central domain forms a “lid” that clamps down over the active site upon nucleotide binding (7,
8). Using the structures of D-ala D-ala ligase and glutathione synthetase, Artymiuk et al.
identified several active site residues of biotin carboxylase as potentially important for catalysis;
among these were Lys 116, Lys 159, His 209, Lys 238, Glu 276, Glu 288 and Asn 290. Soon
after the observations of Artymiuk et al., the three dimensional structure of carbamyl phosphate
synthetase was reported and found to be homologous to biotin carboxylase, D-ala D-ala ligase,
and glutathione synthetase (9). The structural and mechanistic similarity of all four enzymes
suggested they were linked through evolution and thus they became the charter members of the
ATP-grasp family of enzymes. The name “ATP-grasp” derives from the novel nucleotide-
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binding fold observed in these enzymes. The ATP-grasp family of enzymes expanded even
further to include several enzymes involved in purine biosynthesis based on a position specific
iterative BLAST sequence alignment (6, 10). The three-dimensional structure of two of these
enzymes, N5-carboxyaminoimidazole ribonucleotide synthetase (11) and glycinamide
ribonucleotide transformylase, (12) have been determined with nucleotides bound.
The sequence analysis studies identified several residues as being strictly conserved
throughout the entire ATP-grasp family of enzymes. Not surprisingly, the conserved residues in
biotin carboxylase were Lys 116, Lys 159, His 209, Glu 276, Glu 288, and Asn 290. Sitedirected mutagenesis studies of Glu 288 and Asn 290 confirmed that these two residues were
indeed important for catalysis (13). In fact, mutation of Glu 288 to lysine resulted in a
completely inactive mutant (14). Recently, Thoden et al. determined the crystal structure of the
inactive mutant of biotin carboxylase, E288K, cocrystallized with ATP. The structure showed
that the B-domain of biotin carboxylase does exhibit the characteristic “trap door” closure in the
presence of nucleotide, with some atoms moving by more than 8 Å. (14). As expected,
comparison of the structure of the mutant biotin carboxylase-ATP complex with the structures of
the other enzymes of the ATP-grasp superfamily revealed a significant degree of homology. For
example, Lys 116 of biotin carboxylase and the residue homologous to Lys 116 in the other
ATP-grasp enzymes was found to interact with ATP. However, there were also some notable
differences between the structure of biotin carboxylase and the structures of the other ATP-grasp
enzymes. Namely, the biotin carboxylase crystal structure suggested that Lys 159, His 209 and
Glu 276 did not interact with ATP while the structures of the other ATP-grasp enzymes indicated
these residues did interact with ATP. Thus, the objective of this study is to test the hypothesis
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that residues Lys 116, Lys 159, His 209 and Glu 276 of biotin carboxylase are involved in
binding ATP.
Materials and Methods
Chemicals and Enzymes. Sodium bicarbonate labeled with 14C was from Amersham and
had a specific activity of 0.1 mCi/mmol. His-binding resin was from Novagen. Pyruvate kinase
was from Roche Molecular Biochemicals. Restriction grade bovine thrombin was from Enzyme
Research Laboratories. Primers were synthesized by Life Technologies, Inc. All other reagents
were from Sigma or Aldrich. The growth and purification of wild type and mutant forms of
biotin carboxylase were performed as previously described (13).
Site-directed Mutagenesis. Site-directed mutagenesis of biotin carboxylase was carried
out by the PCR method of overlap extension as previously described (13). The following
mutants were constructed: H209A, E276Q, K159Q, K116Q, and K116A. The pairs of internal
mutagenic primers used to make each site-directed mutant can be found in Table 2.1. The entire
gene of each mutant was sequenced to confirm that the desired mutation was made and that no
other mutations were incorporated during polymerase chain reaction.
Enzymatic Assays. The rate of ATP hydrolysis by biotin carboxylase in the absence or
presence of biotin was measured spectrophotometrically by coupling the production of ADP to
pyruvate kinase and lactate dehydrogenase and monitoring the oxidation of NADH at 340 nm.
Each assay contained 0.5 mM phosphoenolpyruvate, 0.2 mM NADH, 10 units of pyruvate
kinase, 18 units of lactate dehydrogenase, and 100 mM HEPES at pH 8. To ensure the formation
of the MgATP complex, MgCl2 was included at concentrations at least twice that of the highest
concentration of ATP in each assay. Since the Km for biotin is high (134 mM), the ionic strength
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Table 2.1. Primers Used for Site-Directed Mutagenesis of Biotin Carboxylase

Enzyme
K116Q

DNA Sequence
5’ GATTGCGGATACTTGGTCGCCCATCAG 3’
5’ CTGATGGGCGACCAAGTATCCGCAATC 3’

K116A

5’ GATTGCGGATACTGCGTCGCCCATCAG 3’
5’ CTGATGGGCGACGCAGTATCCGCAATC 3’

K159Q

5’ CCGCCGGAGGCTTGGATAATCACCG 3’
5’ CGGTGATTATCCAAGCCTCCGGCGG 3’

H209A

5’ CTGAATCTCGACGGCGCGAGGATTTTC 3’
5’ GAAAATCCTCGCGCCGTCGAGATTCAG 3’

E276Q

5’ TCGAACAGGAACTGGAAAGTACCTG 3’
5’ CAGGTACTTTCCAGTTCCTGTTCGA 3’

The underlined bases indicate the nucleotide positions that were changed.
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of the reaction mixture was held constant with KCl when the initial velocities were measured as
a function of biotin concentration.
For experiments in which bicarbonate was varied, all solutions (except for coupling
enzymes, which were diluted into degassed buffers) were degassed in order to lower the level of
endogenous bicarbonate (13) and stored in septum vials capped with rubber septa. All assay
reactions were performed in a total volume of 1 mL and included the following components: 60
mM biotin, 0.5 mM phosphoenolpyruvate, 0.2 mM NADH, 21 units of pyruvate kinase, 35 units
of lactate dehydrogenase, and 100 mM HEPES at pH 8.
For experiments in which the concentration of magnesium was varied, the N-terminal
His-tag on biotin carboxylase was removed by thrombin cleavage to eliminate the possibility of
magnesium binding to the His-tag (13). A ratio of 2 units of thrombin per unit of biotin
carboxylase was used.
The rate of ATP synthesis from MgADP and carbamyl phosphate was determined
spectrophotometrically. The formation of ATP was coupled to hexokinase and glucose-6phosphate dehydrogenase, with the production of NADPH monitored at 340 nm. Each assay
contained 0.5 mM glucose, 0.4 mM NADP, 2.5 units of hexokinase, 2.5 units of glucose-6phosphate dehydrogenase, 100 mM KCl, and 100 mM HEPES at pH 8. To ensure the formation
of the MgADP complex, MgCl2 was included and held at concentrations at least twice that of the
highest concentration of ADP in the assay.
Initial velocities were measured using a Uvikon 810 (Kontron Instruments)
spectrophotometer interfaced to a PC equipped with a data acquisition program. The
temperature of the reactions was maintained at 250 C by a circulating water bath. All reactions
were initiated by the addition of enzyme. Kinetic parameters were calculated per active site
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using a MW of 50,000 daltons for the biotin carboxylase monomer (biotin carboxylase exists as a
homodimer).
To determine if there was a stoichiometric production of ADP and carboxybiotin, the
amount of carboxybiotin produced by biotin carboxylase was determined using a 14C fixation
assay and compared to the production of ADP as previously described (13). The reaction
mixtures contained 20 mM ATP, 70 mM bicarbonate, 100 mM biotin, 50 mM MgCl2, and 100
mM HEPES at pH 8 in a total volume of 0.5 mL.
Data Analysis. The Km and Vmax parameters were determined by nonlinear regression
analysis of the velocity versus [substrate] data to the Michaelis-Menten equation using the
program Enzfitter.
Results
Bicarbonate-Dependent ATPase Reaction. In the absence of biotin, biotin carboxylase
from E. coli catalyzes a bicarbonate-dependent ATP hydrolysis (Scheme 2.2):

-

HCO3

MgADP + Pi

MgATP + H2O
Scheme 2.2

This reaction has been proposed to occur via formation of carboxyphosphate, which rapidly
decomposes in the absence of biotin (15). The Michaelis constants for ATP and the maximal
velocity of this partial reaction were determined for the wild-type enzyme and four mutant
enzymes of biotin carboxylase (Table 2.2). All four mutants showed no significant change in
Vmax when compared to the wild-type enzyme. However, the Km for ATP for all four mutants
increased between 40- and 90- fold.
The Km for bicarbonate for each of the mutants was determined at fixed, nonsaturating
levels of ATP and biotin. Since it was not possible to achieve saturation with biotin or with
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Table 2.2. Kinetic Parameters for the Bicarbonate-Dependent ATPase Reaction

Km ATP
(mM)

Vmax
(min-1)

V/KATP
(mM-1 min-1)

Wild Type

Km
HCO3(mM)
1.1 ± 0.3

0.08 ± 0.01a

0.073 ± 0.001a

0.9 ± 0.1a

H209A

16.7 ± 1.0

5.7 ± 1.2

0.043 ± 0.004

0.008 ± 0.002

E276Q

1.9 ± 0.1

3.0 ± 0.2

0.072 ± 0.002

0.024 ± 0.002

K159Q

1.8 ± 0.2

7.4 ±1.4

0.087 ± 0.009

0.012 ± 0.004

K116Q

1.3 ± 0.1

4.2 ± 0.8

0.075 ± 0.007

0.018 ± 0.005

The kinetic parameters were determined by varying [ATP] at a constant saturating level
of bicarbonate or by varying [KHCO3] while holding ATP at 25 mM. For all mutants
except H209A, 60 mM biotin was included in assays in which bicarbonate was varied.
The residual bicarbonate in the solutions prevented kinetic analysis unless biotin was
added to the reaction to stimulate rates of catalysis. Biotin was excluded from the assays
for H209A because the Km for bicarbonate was high enough that accurate rates of catalyis
could be obtained at subsaturating concentrations of bicarbonate. Standard errors on Km
and Vmax were calculated from nonlinear regression analysis. The error on V/K was
calculated by standard propagation of the errors from Km and Vmax. a Data taken from
ref. 13.
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ATP, the Km values for bicarbonate are apparent Km values. The apparent Km values for wild
type biotin carboxylase and the four mutants are shown in Table 2.2. The mutations did not
affect significantly the apparent Km for any mutant except that of H209A, where the Km was 15
times greater than that of wild type.
Biotin-Dependent ATPase Reaction. In the presence of biotin, biotin carboxylase from
E. coli catalyzes the phosphorylation of bicarbonate by ATP to form a carboxyphosphate
intermediate. The carboxyl group is then transferred from carboxyphosphate to biotin to form
carboxybiotin. When ATP hydrolysis activity was examined in the presence of biotin, the Km
values for biotin for all mutants were not significantly different compared to the wild type
enzyme (Table 2.3). The Km values for biotin are apparent because it was not possible to
saturate with ATP. The largest change in Km was exhibited by H209A, but was less than 10 fold.
However, Vmax for three of the four mutants decreased significantly between 30- and 200-fold.
The one exception is K116Q, for which a Km value could not be obtained; the activity of this
mutant did not increase with the addition of biotin over a range of 1-300 mM. To further
investigate the role of this lysine residue in the biotin-dependent ATPase reaction, a K116A
mutant was constructed and the initial velocity as a function of biotin concentration was
measured. The Km for biotin for the K116A mutant was 147 ± 12 mM while the maximal
velocity was 1.03 ± 0.04 min-1. The effect of this mutation was similar to that of the other three
in that the Vmax rather than the Km was significantly altered with respect to wild type. These data
suggest that the lack of stimulation of ATP hydrolysis by biotin for K116Q reflects a function of
the mutant glutamine residue rather than of the role of the native lysine residue.
Since the ATPase assay measures the production of ADP in the presence and absence of
biotin, the question still remained as to whether carboxybiotin was being produced by the mutant
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Table 2.3. Kinetic Parameters for the Biotin-Dependent ATPase Reaction

Wild Typea

Km biotin
(mM)
134 ± 12

Vmax
(min-1)
78.6 ± 7

V/Kbiotin
(mM-1 min-1)
0.59 ± 0.11

H209A

1234 ± 117

2.49 ± 0.17

0.0020 ± 0.0003

E276Q

137 ± 24

0.90 ± 0.06

0.006 ± 0.001

K159Q

125 ±10

0.37 ± 0.01

0.0030 ± 0.0004

K116Q

*

*

*

The kinetic parameters were determined by varying [biotin] at constant saturating levels
of bicarbonate and 25 mM ATP. The standard errors on Vmax and Km were calculated
from nonlinear regression analysis. The error on V/K was calculated by standard
propagation of the errors from Km and Vmax. Because the ATPase activity for K116Q
responded very little to concentrations of biotin between 20 and 300 mM, kinetic
parameters could not be obtained for K116Q. a Data taken from ref. 13.
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enzymes. In other words, is there a 1:1 stoichiometry for the formation of ADP and
carboxybiotin or is the hydrolysis of ATP uncoupled from the formation of carboxybiotin? If the
1:1 ratio were altered, this would suggest that the mutations had affected the carboxyl transfer
step. The ratio of carboxybiotin to ADP produced during the ATPase reaction for wild type and
the four mutants was determined (Table 2.4). All four mutants produced a ratio of carboxybiotin
to ADP that was nearly 1:1. These results indicate that the mutations did not prevent the
production of carboxybiotin and therefore the carboxyl transfer step had not been uncoupled
from the hydrolysis of ATP.
ATP Synthesis Reaction. Biotin carboxylase from E. coli has been shown to catalyze the
transfer of the phosphoryl group of carbamyl phosphate to ADP to form ATP and carbamate as
follows.
MgADP + Carbamyl phosphate

MgATP + Carbamate

Scheme 2.3
The carbamate rapidly decomposes to carbon dioxide and ammonia. Scheme 2.3 represents the
reverse of Scheme 2.2 with carbamyl phosphate acting as an analog of the putative
carboxyphosphate intermediate. Although biotin does not participate in the chemistry of this
reaction, its presence does stimulate the rate of phosphoryl transfer (16).
The kinetic parameters for the ATP synthesis reaction were determined in the absence of
biotin (Table 2.5). The mutations did not have a significant effect on the Km for either carbamyl
phosphate or ADP. However, a modest decrease in Vmax of 4-fold or less was observed.
To test the ability of biotin to stimulate the phosphoryl transfer reaction of the wild type
and four mutants of biotin carboxylase, initial velocities were measured at a saturating
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Table 2.4. Ratio of ADP to Carboxybiotin Production

Wild Typea

0.96 ± 0.18

H209A

1.2 ± 0.1

E276Q

0.86 ± 0.01

K159Q

0.78 ± 0.16

K116Q

1.1 ± 0.1

The amounts of ADP and carboxybiotin formed over a 1 hour period were quantified as
described in Materials and Methods. a Data taken from ref. 13.
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Table 2.5. Kinetic Parameters for the ATP Synthesis Reaction

Wild Typea

Km CbmP
(mM)
4.8 ± 0.2

Km ADP
(mM)
0.19 ± 0.01

Vmax
(min-1)
0.31 ± 0.01

V/KADP
(mM-1 min-1)
1.6 ± 0.1

H209A

7.3 ± 0.5

0.39 ± 0.07

0.12 ± 0.01

0.31 ± 0.08

E276Q

2.3 ± 0.1

0.42 ± 0.01

0.087 ± 0.001

0.21 ± 0.01

K159Q

3.0 ± 0.6

0.93 ± 0.08

0.12 ± 0.01

0.13 ± 0.02

K116Q

5.0 ± 0.7

0.31 ± 0.05

0.077 ± 0.003

0.25 ± 0.05

The kinetic parameters were determined by varying carbamyl phosphate concentration
(CbmP) at constant saturating levels of ADP or varying [ADP] at constant saturating
levels of CbmP. The standard errors on Km and Vmax were calculated from nonlinear
regression analysis. The error on V/K was calculated by standard propagation of the
errors on Km and Vmax. a Data taken from ref. 24.
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concentrations of ADP and carbamyl phosphate, both in the absence and presence of 60 mM
biotin (Table 2.6). The degree of stimulation of the ATP synthesis activity by biotin was
decreased 10 fold by the E276Q mutation, while the H209A mutant showed no significant
decrease in stimulation. Both K116Q and K159Q showed a decrease of ~2.5-fold compared to
wild type.
Magnesium Assay. Biotin carboxylase requires two equivalents of magnesium for
activity. One equivalent is complexed to ATP while the role of the other equivalent is unknown.
The effect of the four mutations on the ability of magnesium to stimulate the biotin-dependent
ATPase activity of wild type and mutant biotin carboxylase was evaluated by measuring initial
velocity as a function of [MgCl2]. All four mutants exhibited a dependence on MgCl2 similar to
that of wild type. This suggests that these mutations did not affect the enzyme’s affinity for
magnesium (Figure 2.1).
Discussion
The initial objective of this study was to test the hypothesis that four residues of biotin
carboxylase, Lys 116, Lys 159, Glu 276, and His 209, were involved in binding ATP. Each of
the corresponding site-directed mutants displayed an elevated Km value for ATP relative to the
wild type value. This suggests that all four conserved active site residues bind ATP. For the
K116Q mutant, the increased Km value for ATP is consistent with the three-dimensional
structure of biotin carboxylase with ATP bound as well as with the three-dimensional structures
of other ATP-grasp enzymes bound to ADP or AMPPNP. The crystal structure of biotin
carboxylase complexed with ATP revealed an electrostatic interaction between the ε-amino
group of Lys 116 and the α-phosphoryl oxygen of ATP (14). As shown in Table 2.7, the
residues homologous to Lys 116 in enzymes of the ATP-grasp family also interacted with the
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Table 2.6. Stimulation of ATP Synthesis Reaction

Stimulation
factor
25
Wild Type
21
H209A
2
E276Q
9
K159Q
10
K116Q

The initial velocity of the ATP synthesis reaction was measured both in the presence and
absence of 60 mM biotin. All reactions contained saturating levels of ADP, carbamyl
phosphate, and magnesium. The stimulation factor is the ratio of the rate with biotin to
the rate without biotin.
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100

% Maximal Activity

80

60
Wild Type
K116Q
K159Q
H209A
E276Q

40

20

0

0

2
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6

8

10

[Mg2+], mM

Figure 2.1. The effect of magnesium on the ATPase activity of wild type biotin
carboxylase and the four mutants: K116Q, K159Q, H209A and E276Q. Initial velocities
were measured at constant levels of ATP, bicarbonate, and biotin with increasing
amounts of MgCl2. The degree of stimulation of the reaction by MgCl2 is expressed as a
percentage of the maximum rate measured for each of the mutants and wild type.
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oxygens of the α or β phosphates, as determined by crystallography. Moreover, mutation of the
homologous residue in the carboxyphosphate domain of carbamyl phosphate synthetase resulted
in a 5-fold increase in the Km for ATP (17).
Although all the available crystallographic and kinetic data implicate Lys 116 in binding
an α or β phosphate oxygen, roles for the other three residues are not as well defined. Sitedirected mutagenesis data for biotin carboxylase and the crystal structures of other ATP-grasp
enzymes suggest differing roles for Lys 159, His 209, and Glu 276. First, the ε-amino group of
Lys 159 was not implicated in ATP binding based on the crystal structure of biotin carboxylase
complexed with ATP. However, the residues homologous to Lys 159 in other ATP-grasp
enzymes have been shown to interact with the nucleotide (Table 2.7), which supports the 90-fold
increase in Km for ATP in the K159Q mutant of biotin carboxylase. Site-directed mutagenesis of
the homologous residues of carbamyl phosphate synthetase (carboxyphosphate domain) and Dala D-ala ligase revealed a Km for ATP that was 31-fold and 50-fold higher than the wild type
value, respectively (17, 18). Together these data implicate Lys 159 in binding to ATP.
Second, the crystal structure of biotin carboxylase complexed with ATP showed that the
imidazole group of His 209 is about 4Å from the hydroxyl groups of the ribose of ATP, whereas
the crystal structures of other ATP-grasp enzymes showed that the residue homologous to His
209 hydrogen bonded to the 2’ and 3’ hydroxyl groups of the ribose (Table 2.7). As with
K159Q, the Km for ATP in the H209A mutant of biotin carboxylase was elevated 70-fold relative
to wild type. Again, the structural data from other ATP-grasp enzymes and the site-directed
mutagenesis results of biotin carboxylase strongly suggest that His 209 interacts with ATP,
presumably with the hydroxyl groups of ribose.
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Table 2.7. Homologous residues in ATP-grasp enzymes

Residue in
Biotin
Carboxylase

D-ala D-ala Ligaseb

Carbamyl Phosphate
Synthetase,
carboxyphosphate domainc
R129 hydrogen bonds with
α?and β phosphoryl
groups of ATP

Carbamyl Phosphate
Synthetase, carbamyl
phosphate domainc
R675 hydrogen bonds with β
phosphoryl group of
ATP

N5-Carboxyaminoimidazole
Ribonucleotide Synthetased

Glycinamide
Ribonucleotide
Transformylasee

R80 hydrogen bonds with α R114 hydrogen bonds
with?β phosphoryl
and β phosphoryl group
group of ATP
of ATP

K116

K97 hydrogen bonds
with α and β
phosphoryl
groups of ATP

K159

K144 hydrogen bonds R169 hydrogen bonds with α R715 hydrogen bonds with α K120 interacts with α
with α phosphate
phosphate group
phosphate group
phosphoryl and N7 of
group
adenine

H209

E187 hydrogen bonds
to ribose
hydroxyl groups

E215 hydrogen bonds to
ribose hydroxyl groups

E276

D257 coordinated to
magnesium

Q285 hydrogen bonds with α Q829 coordinated to
manganese
phosphate group

E161 hydrogen bonds to
E761 hydrogen bonds to
ribose hydroxyl groups
ribose hydroxyl groups

E226 coordinated to
magnesium

K155 hydrogen bonds
with α phosphate
group

E203 hydrogen bonds to
ribose hydroxyl
groups

E267 coordinated to
magnesium

These enzymes were chosen for structural comparison with biotin carboxylase because of their known three-dimensional
structures with bound nucleotide or nucleotide analog. a-d Data taken from Refs. 6, 27, 11, and 12, respectively.
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Third, when the three-dimensional structure of biotin carboxylase with ATP was modeled
with bound biotin, the ureido ring of biotin was located near the side chain of Glu 276 (14).
However, three-dimensional structures of other ATP-grasp enzymes showed that the residue
homologous to Glu 276 coordinated to either magnesium or manganese, and that the divalent
cation in each structure coordinated to the phosphoryl oxygens of the γ phosphate group (Table
2.7). Site-directed mutagenesis of Glu 276 in biotin carboxylase indicated no change in the Km
for biotin but a nearly 40-fold increase in the Km for ATP. This result supports the hypothesis
that Glu 276 coordinates to a magnesium ion in biotin carboxylase and that mutation of Glu 276
distorts the binding of magnesium and in turn the binding of ATP. It should be noted that while
the mutation of Glu 276 altered the binding of magnesium ion to the residue, it does not appear
to change the affinity of magnesium for the enzyme (Figure 2.1). Additionally, when the
homologous residue in the carboxyphosphate domain of carbamyl phosphate synthetase was
mutated to alanine, the Km for ATP for the resulting mutant was 19-fold higher than wild type
carbamyl phosphate synthetase (17). Again, the mutagenesis data on biotin carboxylase were
consistent with the structures and mutagenesis data of the other ATP-grasp enzymes, and
inconsistent with the biotin carboxylase structure complexed with ATP.
The discrepancies described above can be explained by noting that the biotin carboxylase
used in the crystal structure complexed with ATP contained a mutation of a critical residue
(E288K) leading to a complete loss of activity. Although this mutation crippled the ability of the
enzyme to hydrolyze ATP, it allowed crystals to be grown in the presence of ATP. The
structural data from the other ATP-grasp enzymes in Table 2.7 were obtained from wild type
protein. Furthermore, the crystal structure of biotin carboxylase does not contain a divalent
cation coordinated to ATP. Thus, the crystal structure of the E288K mutant form of biotin
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carboxylase complexed with ATP may not be a completely accurate description of the binding of
ATP to this enzyme, which would explain the disagreement between the mutagenesis data and
the crystal structure. Moreover, the evidence that ATP is bound incorrectly in the E288K mutant
of biotin carboxylase may explain, at least in part, the lack of activity for the E288K mutant and
provide insight into why the maximal velocities of the biotin-dependent ATPase activity for the
four mutants characterized in this paper are significantly decreased.
While the increase in the Michaelis constants of the four mutants of biotin carboxylase
strongly suggests that these residues are involved in binding ATP, the concomitant decrease in
their maximal velocities indicates that these residues also play a role in catalysis. If these four
residues were solely involved in binding ATP, then the corresponding mutants should have the
same maximal velocity as wild type biotin carboxylase. This brings us to the question of what
role these residues could play in catalysis that would be consistent with their role in binding
ATP. Any discussion of the catalytic roles of these residues must begin with the observation that
biotin carboxylase exhibits the phenomenon of substrate-induced synergism with respect to
biotin (13). That is, in the absence of biotin, the enzyme will cleave ATP into ADP and Pi in a
bicarbonate-dependent manner, albeit at a very slow rate. However, in the presence of biotin, the
rate of ATP hydrolysis increases 1100-fold. Thus, the hydrolysis of ATP is synergistic with the
binding of biotin. A possible explanation for substrate-induced synergism in biotin carboxylase
that is consistent with the data presented in this paper is that in the absence of biotin, ATP binds
to the enzyme in a large number of non-productive modes, which is manifested as a low maximal
velocity. However, upon the binding of biotin to biotin carboxylase, the number of nonproductive binding modes of ATP is reduced, allowing for a more reactive alignment of the
substrates. This phenomenon is manifested as a dramatic increase in the maximal velocity.
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Recently, a more sophisticated version of this concept has been proposed (19, 20). In the current
theory, the enzyme molecule pre-organizes the active site to allow the substrates to form “near
attack conformers” or NAC for short. A NAC refers to the juxtaposition of the substrates in the
ground state such that they closely resemble the transition state. The effect of mutating any of
the four residues in this study would be a shift in the active site geometry which would possibly
reduce the number of near attack conformers. This is manifested as a significantly reduced
maximal velocity for the mutant enzyme. Biotin cannot properly cause the alignment of ATP for
the reaction because of greater conformational flexibility of ATP in the active site due to the
mutation. This concept of greater conformational flexibility of ATP is supported by both the
increase in Km for ATP in each of the mutant enzymes and the presumably incorrect binding of
ATP in the active site of the inactive E288K mutant. Recall that none of the mutants affected the
carboxyl transfer from carboxyphosphate to biotin, yet the Vmax values were significantly
decreased. Thus, the fact that these four ATP-binding residues are conserved throughout the
ATP-grasp superfamily of enzymes further attests to the notion that binding interactions and
correct positioning of the substrates appear to play the dominant role in catalysis by biotin
carboxylase.
The question is now how does biotin organize the substrates into a more reactive
conformation. A conformational change (i.e., induced fit) in biotin carboxylase upon biotin
binding could explain the large increase in rate for ATP hydrolysis. However, the major
conformational change in biotin carboxylase occurs upon the binding of ATP (14), which binds
to the enzyme first before bicarbonate and biotin (21). A crystal structure of biotin carboxylase
with only biotin bound showed no difference in conformation compared with the unliganded
structure of the enzyme (4). The lack of a large conformational change in biotin carboxylase
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upon binding biotin is consistent with the high Km for biotin (134 mM); using this value as an
apparent binding constant for biotin, a relatively low binding energy of 1.2 kcal/mole is obtained.
The low binding energy of biotin to the enzyme is not suggestive of a large conformational
change.
How then is biotin able to stimulate the rate of ATP hydrolysis, if not via a
conformational change? Perhaps biotin only promotes very small changes in the enzyme that
result in the alignment of substrates for catalysis. To this end, recent studies on hydrogen
tunneling in dehydrogenases have found a correlation between protein dynamics and enzymatic
activity (22, 23). Particularly intriguing is the case of isocitrate dehydrogenase, to which the
binding of its substrate, isocitrate, induces shifts of less than an angstrom in the amino acid side
chains of the active site. These seemingly insignificant changes in conformation are in fact,
related to rate increases of many orders of magnitude (24, 25). Thus, it may be that very subtle
dynamic behavior of biotin carboxylase is enough to generate the large increase in the rate of
ATP hydrolysis upon the binding of biotin. Further studies will be required to determine this
aspect of the mechanism.
In summary, the four active site residues of biotin carboxylase, Lys 116, Lys 159, His
209, and Glu 276, were shown to be involved in binding ATP. Furthermore, these four residues
have also been found to be involved in catalysis, and their role in catalysis is to orient ATP in the
correct conformation that allows for optimal catalysis. Finally, the results also suggest that the
crystal structure of the mutant biotin carboxylase, E288K complexed with ATP, may not be a
completely accurate depiction for the binding of ATP to the wild type form of biotin
carboxylase.
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CHAPTER 3
KINETIC CHARACERIZATION OF MUTATIONS FOUND IN PROPIONIC
ACIDEMIA AND METHYLCROTONYL GLYCINURIA: EVIDENCE FOR
NEGATIVE COOPERATIVITY IN BIOTIN CARBOXYLASE

Introduction
For over 20 years site-directed mutagenesis has been used to determine the roles of active
site residues in enzyme-catalyzed reactions. In designing such experiments, one is invariably
faced with the question of which residue to mutate and what to mutate it to. Residues targeted
for mutagenesis are usually identified using three-dimensional structural information or sequence
alignments with homologous proteins indicating which residues are highly conserved. Once
residues for mutagenesis are identified, they are commonly replaced with an isosteric residue or
alanine (i.e. alanine scanning mutagenesis) in order to minimize disruption of the protein
structure. However, prior to the advent of site-directed mutagenesis, mutant human hemoglobins
provided the only opportunity to study structure-function relationships in proteins. Many of
these hemoglobinopathies involved amino acid replacements that would not normally be made
using site-directed mutagenesis out of concern for disruption of the protein structure. Yet these
mutations yielded important insight into how hemoglobin functioned (1). In this report, we take
this classical approach to mutagenesis to examine the effect of three naturally occurring
mutations found in biotin-dependent carboxylases on the catalytic mechanism of E. coli biotin
carboxylase.
Biotin carboxylase is one component of the multifunctional enzyme acetyl-CoA
carboxylase, which catalyzes the first committed step in long chain fatty acid biosynthesis (2).
Acetyl-CoA carboxylase is a biotin-dependent enzyme that catalyzes the following two-step
reaction (Scheme 3.1).
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Mg2+
Enzyme-biotin-CO2- + MgADP + Pi

(1) Enzyme-biotin + MgATP + HCO3(2) Enzyme-biotin-CO2- + Acetyl CoA

Malonyl CoA + Enzyme-biotin

Scheme 3.1

Biotin carboxylase catalyzes the first-half reaction, which is an ATP-dependent carboxylation of
biotin to form carboxybiotin. Biotin is covalently attached to the biotin carboxyl carrier protein
designated Enzyme-biotin in Scheme 3.1. The second-half reaction is catalyzed by
carboxyltransferase, which involves the transfer of the carboxyl group from carboxybiotin to
acetyl-CoA to make malonyl-CoA. Animal acetyl-CoA carboxylase incorporates all three of
these functions on a single polypeptide chain (3), while in the bacterial form each function is a
separate protein (4).
There have been no documented naturally occurring mutations in acetyl-CoA carboxylase
leading to an inborn error of metabolism. However, there are two related biotin-dependent
carboxylases in which naturally occurring mutations have been detected. Propionyl-CoA
carboxylase is involved in the catabolism of odd chain length fatty acids and branched chain
amino acids and mutations in the human form of this enzyme result in the condition propionic
acidemia (5). The enzyme 3-methylcrotonyl-CoA carboxylase is involved in the catabolism of
leucine and mutations in the human form of this enzyme result in methylcrotonylglycinuria (6).
Both propionyl-CoA carboxylase and 3-methylcrotonyl-CoA carboxylase catalyze their
respective reactions via a two-step reaction sequence similar to the reaction catalyzed by acetylCoA carboxylase (Scheme 3.1). In fact, the first half-reaction in Scheme 3.1, the carboxylation
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of biotin, is identical for all three enzymes. That is, propionyl-CoA carboxylase and 3methylcrotonyl-CoA carboxylase have a biotin carboxylase domain homologous to the biotin
carboxylase domain of acetyl-CoA carboxylase. Although the genes for both propionyl-CoA
carboxylase and 3-methylcrotonyl-CoA carboxylase have been cloned and several diseasecausing missense mutations identified, characterization of the mutant proteins has been limited to
specific activity measurements of fibroblast extracts (7). This is due to the lack of a system for
structure-function studies of these two enzymes. In contrast, the biotin carboxylase subunit of E.
coli acetyl-CoA carboxylase provides an ideal model system to conduct a rigorous kinetic
analysis of mutations found in propionyl-CoA carboxylase and 3-methylcrotonyl-CoA
carboxylase. In fact, ten active site mutants of E. coli biotin carboxylase have been characterized
to date (8, 9, 10). Kinetic characterization of these naturally occurring mutants using E. coli
biotin carboxylase as a model may lend insight into the structure and function of the enzyme.
The advantage of using E. coli biotin carboxylase for kinetic analysis is that the
homodimer can be isolated and that it retains catalytic activity in the absence of the other two
components (11). Moreover, biotin carboxylase is able to utilize free biotin as a substrate instead
of biotin linked to the biotin carboxyl carrier protein, thereby simplifying kinetic analysis (11).
The availability of structural information is perhaps the most significant feature of E. coli biotin
carboxylase that makes it the paradigm for mechanistic studies of biotin-dependent enzymes.
The three-dimensional structure of biotin carboxylase has been determined by x-ray
crystallography and to date is the only structural model of a biotin-dependent carboxylase (12,
13). Based on this crystal structure, two mutations in the biotin carboxylase domain of human
propionyl-CoA carboxylase, M204K and R374Q, were predicted to be in the active site (5, 14).
According to sequence alignments of the human propionyl-CoA carboxylase and E. coli biotin
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carboxylase, the homologous residues in the E. coli enzyme are Met 169 and Arg 338 (Figure
3.1). In patients with methylcrotonylglycinuria, only one mutation of 3-methylcrotonyl-CoA
carboxylase, R385S, was predicted to lie in the active site of the biotin carboxylase domain (6).
Interestingly, this residue also corresponds to Arg 338 of E. coli biotin carboxylase (Figure 3.1).
In this report, these three mutations, M169K, R338Q, and R338S, were constructed in E. coli
biotin carboxylase and the mutant enzymes were subjected to kinetic characterization. The
results not only suggest a molecular basis for understanding how these mutations cause disease,
but also provide the first kinetic evidence for cooperativity between the subunits of E. coli biotin
carboxylase.
Materials and Methods
Chemicals and Enzymes.

14

C-labeled sodium bicarbonate was purchased from

Amersham Pharmacia Biotech and had a specific activity of 0.1 mCi/mmol. His Bind resin was
purchased from Novagen. DEAE cellulose resin was manufactured by Whatman. Pyruvate
kinase was obtained from Boehringer Mannheim. All other reagents were from Sigma or
Aldrich.
Site-Directed Mutagenesis. Construction of biotin carboxylase mutants was performed
by the PCR method of overlap extension as described by Blanchard et al. (8). All primers were
synthesized by Life Technologies, Inc. Mutagenic internal primers for the M169K, R338Q, and
R338S mutants were used to incorporate the desired mutation. The mutagenic primer sequences
were as follows: M169K: 5’GCGCACTACGCGCTTACCGCGACCGCC3’ and
5’GGCGGTCGCGGTAAGCGCGTAGTGCGC3’; R338Q:
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Figure 3.1. Amino acid sequences of biotin-dependent carboxylases. The regions of
Homo sapiens propionyl-CoA carboxylase (HsPCC) and Homo sapiens 3methylcrotonyl-CoA carboxylase (HsMCC) containing residues homologous to Met 169
and Arg 338 of E. coli biotin carboxylase (EcBC) are shown. The figure was created
using Alscript (25).
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5’TTCGGCGTTGATTTGACATTCCACCGC3’ and
5’GCGGTGGAATGTCAAATCAACGCCGAA3’; R338S:
5’TTCGGCGTTGATAGAACATTCCACCGC3’ and
5’GCGGTGGAATGTTCTATCAACGCCGAA3’. The entire gene of each mutant was
sequenced to confirm that only the desired mutation was incorporated.
Overexpression and Purification of Biotin Carboxylase. The growth and overexpression
of wild type and mutant biotin carboxylase was performed as described by Blanchard et al. (8).
Biotin carboxylase was purified by nickel affinity chromatography using His-Tag columns as
described elsewhere (8) and the eluate from the His Bind resin was dialyzed overnight against
buffer A (10 mM NaCl, 50 mM KH2PO4, pH 7.1) and was then applied to a DEAE cellulose
column. The column was washed with 14 volumes of buffer A. The flowthrough and wash
volumes were pooled and the protein was precipitated by the addition of ammonium sulfate to
60% saturation. The precipitate was dissolved and dialyzed against 500 mM KCl, 10 mM
HEPES, pH 7.0. The resulting solution was then concentrated by vacuum dialysis using a
collodion bag apparatus. Protein concentrations were determined by the Bio-Rad protein assay
with BSA as a standard.
Kinetic Assays. The rate of ATP hydrolysis by biotin carboxylase was measured
spectrophotometrically by coupling the formation of ADP to pyruvate kinase and lactate
dehydrogenase and monitoring the oxidation of NADH at 340 nm. Each assay was conducted in
the presence of 0.5 mM phosphoenolpyruvate, 0.4 mM NADH, 23 units of pyruvate kinase, 35
units of lactate dehydrogenase, and 100 mM HEPES at pH 8. Since the Km for biotin is high
(134 mM), the ionic strength was kept constant with KCl in assays where biotin was varied.
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The rate of ATP synthesis from Mg-ADP and carbamyl phosphate was measured
spectrophotometrically. The formation of ATP was coupled to hexokinase and glucose-6phosphate dehydrogenase while the reduction of NADP was followed at 340 nm. Each assay
contained 0.5 mM glucose, 0.4 mM NADP, 5 units of hexokinase, 5 units of glucose-6phosphate dehydrogenase, 100 mM KCl, and 100 mM HEPES at pH 8.
Initial velocities were measured using a Uvikon 810 spectrophotometer (Kontron
Instruments). All reactions were initiated by the addition of enzyme. Kinetic parameters were
calculated per active site using a molecular mass of 50 kDa for the biotin carboxylase monomer
(biotin carboxylase exists as a homodimer). The temperature of the reactions was maintained at
25oC or 37oC by a circulating water bath. For assays conducted at 37oC, all reaction components
were preincubated for six minutes at 37oC prior to mixing in quartz cuvettes. For each initial
velocity measurement, the cuvette was preincubated in the spectrophotometer at 37oC for 10
minutes before addition of the reaction components.
To determine if there was a stoichiometric production of ADP and carboxybiotin, the
amount of carboxybiotin produced by biotin carboxylase was determined using a 14C fixation
assay and compared to the production of ADP as described elsewhere (8). The reaction mixtures
contained 20 mM ATP, 70 mM bicarbonate, 100 mM biotin, 50 mM MgCl2, and 100mM
HEPES at pH 8 in a total volume of 0.5 ml.
Data Analysis. the Km and Vmax were determined by nonlinear regression analysis of the
velocity versus [substrate] data to the Michaelis-Menten equation. For assays in which the
double reciprocal plots appeared hyperbolic, the data were fitted to equation 3.1, where V1 and
V2 are maximal velocities, K1 and K2 are Michaelis constants, and A is the substrate
concentration:
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v = V1A/(K1 + A) + V2A/(K2 + A)

(3.1)

Hill coefficients (nH) were determined by nonlinear regression analysis of the velocity versus
[bicarbonate] data to equation 3.2:

v = Vmax [A]nH / K’ + [A]nH

(3.2)

where A is the substrate concentration and K’ is a constant which depends upon the interaction
between substrate binding sites and the intrinsic dissociation constant of the enzyme-substrate
complex.
Results
Bicarbonate-dependent ATPase Activity. The order of substrate binding to biotin
carboxylase is ordered, with ATP binding first followed by bicarbonate and then biotin (15).
However, in the absence of biotin, the enzyme also catalyzes a slow bicarbonate-dependent ATP
hydrolysis, as shown in Scheme 3.2.

-

HCO3

MgADP + Pi

MgATP + H2O
Scheme 3.2

This reaction involves the transfer of the phosphate group to the bicarbonate, forming
carboxyphosphate, which quickly breaks down into carbon dioxide and inorganic phosphate
(16). When ATP was varied at constant levels of bicarbonate, the kinetic parameters were
determined for the three mutants and wild type. The Vmax values for the three mutants were only
modestly different from the wild type enzyme; R338Q showed a two-fold increase in Vmax and
R338S and M169K showed a two-fold decrease or less (Table 3.1). By contrast, the Km was
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Table 3.1. Kinetic Parameters for the Bicarbonate-Dependent ATPase Reaction

Km ATP
WTa
R338Q
R338S
M169K

Vmax

(mM)

(min-1)

0.081 ± 0.003
4.4 ± 0.3
5.1 ± 0.05
0.26 ± 0.02

0.073 ± 0.001
0.16 ± 0.01
0.045 ± 0.002
0.033 ± 0.001

The kinetic parameters were determined by varying [ATP] at a constant level of
bicarbonate. The concentration of bicarbonate was saturating for wild type, 30 mM for
R338Q, 15 mM for R338S, and 10 mM for M169K. The errors on Km and Vmax were
determined by nonlinear regression analysis. a Data taken from Ref. 8.
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strikingly affected by the R338Q and R338S mutations. Both Km values were elevated by at
least 50-fold compared to wild type, suggesting the mutations have affected the binding affinity
of ATP to the enzyme. The Km for the M169K mutant was only slightly higher (about threefold) than wild type.
Interestingly, when ATP was held constant and bicarbonate varied, the double reciprocal
plots were hyperbolic for all three mutants (Figure 3.2). For all three mutants there was a
significant increase in the velocity at high concentrations of substrate, suggesting substrate
activation with respect to bicarbonate. Substrate activation, also known as negative
cooperativity, was confirmed when the data for the three mutants were fitted to the MichaelisMenten equation and the residuals were nonrandom. By contrast, fitting the data to the equation
for negative cooperativity (Equation 3.2) revealed the residuals to be random. A representative
example of this type of analysis is shown in Figure 3.3 for the M169K mutant. The fitting to
equation 1 also revealed that the Km2 for each of the mutants was greater than 30 mM. For this
reason, the Km values for ATP shown in Table 3.1 are apparent Km values because saturating
levels of bicarbonate could not be achieved.
Particularly intriguing is the fact that the degree of negative cooperativity by bicarbonate
for the three mutants is dependent upon the concentration of biotin. To illustrate this trend, the
Hill coefficients (nH) under different concentrations of biotin are listed in Table 3.2. In the
presence of 60 mM biotin, M169K showed a slight 23% increase in nH relative to the reaction
without biotin. The R338S and R338Q mutants displayed a more dramatic increase in nH (3-fold
and 5-fold, respectively) with 60 mM biotin as opposed to 16 mM biotin. These trends indicate
that biotin decreases the negative cooperativity of the three mutants, particularly for the two Arg
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Figure 3.2. Double reciprocal plots for the bicarbonate-dependent ATPase reaction. (A).
Bicarbonate was varied at a constant saturating level of ATP in the presence of wild type
biotin carboxylase. (B). Bicarbonate was varied at a constant saturating level of ATP in
the presence of M169K. For R338S (C) and R338Q (D), bicarbonate was varied at 20
mM ATP and 16 mM biotin. Data points are experimental velocities and the line is
derived from the best fit of the data to the Michaelis-Menten equation for wild type and
equation 3.1 for the three mutants.
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Table 3.2. Hill Coefficients for the three mutants of biotin carboxylase

[Biotin]

nH

16 mM

0.17 ± 0.03

60 mM

0.79 ± 0.07

16 mM

0.20 ± 0.03

60 mM

0.58 ± 0.05

0 mM

0.29 ± 0.02

60 mM

0.38 ± 0.04

R338Q

R338S

M169K

The Hill Coefficients (nH) were determined by fitting data from the bicarbonatedependent ATPase assays to Equation 3.2. The error on nH was derived from nonlinear
regression analysis.
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338 mutants. Assaying the two Arg 338 mutants in the absence of biotin proved difficult
because the enzymes displayed almost no change in rate when bicarbonate was varied.
Biotin-dependent ATPase Activity. The rate of ATP hydrolysis is increased 1100-fold in
the presence of biotin for the wild-type enzyme (8). However, when the hydrolysis of ATP was
assayed in the presence of biotin for the three mutants, the most notable result was that the Vmax
of R338S and R338Q was 700-fold and 100-fold lower than wild type, respectively (Table 3.3).
The Vmax was also reduced in the M169K mutant, but only by about 10-fold. The Km for biotin
for R338Q was virtually unchanged from that of wild type. The R338S and M169K mutants,
however, showed a 5-fold and 2.5-fold reduction in apparent Km, respectively. Although the
latter two mutants seem to bind biotin with slightly greater affinity than wild type, it is important
to note that the catalytic efficiency (V/K) is 5-fold lower for M169K and 140-fold lower for
R338S. Again, the Km for the three mutants reported here are apparent Km values because it was
not possible to saturate the enzymes with bicarbonate.
Although the assay for the ATPase activity measures the rate of production of ADP using
a continuous assay, the production of carboxybiotin cannot be followed. Thus, the assay cannot
detect whether ATP hydrolysis is uncoupled from the production of carboxybiotin in the
mutants. However, carboxybiotin can be quantified in order to demonstrate whether it is
produced at a 1:1 stoichiometry with ADP. Wild type biotin carboxylase and M169K both
exhibited a normal 1:1 ratio of ADP to carboxybiotin production (Table 3.4). Unexpectedly,
however, R338S and R338Q revealed ratios of 3.0 and 3.8, respectively. This conspicuous
perturbation in the stoichiometry suggests that for the two Arg 338 mutants, the carboxylation of
biotin is uncoupled from ATP hydrolysis. Of the ten site-directed mutants of biotin carboxylase
characterized to date, only one other, K238Q, has exhibited such an uncoupling (9).
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Table 3.3. Kinetic parameters for the Biotin-Dependent ATPase Reaction

Km Biotin
WTa
R338Q
R338S
M169K

Vmax

V/K

(mM)

(min-1)

(mM-1 min-1)

134 ± 14
143 ± 21
25 ± 2
56 ± 6

79 ± 3
0.74 ± 0.05
0.10 ± 0.01
6.7 ± 0.3

0.59 ± 0.08
0.0052 ± 0.0004
0.0041 ± 0.0003
0.12 ± 0.01

The kinetic parameters were obtained by varying [biotin] at constant levels of ATP and
bicarbonate. For all mutants, bicarbonate was held at the same levels as in Table 3.1.
ATP concentration was saturating for M169K and wild type. For R338Q and R338S,
ATP was held at the highest concentration that did not produce substrate inhibition. The
errors on Km, Vmax, and V/K were determined by nonlinear regression analysis.
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Table 3.4. Ratio of ADP to Carboxybiotin Production

WTa
R338Q
R338S
M169K

0.96 ± 0.18
3.8 ± 0.1
3.0 ± 0.1
1.0 ± 0.1

Quantities of ADP and carboxybiotin formed over a 1-hour period were determined as
described in Materials and Methods. The error was derived from the standard deviation
of the mean of at least two separate experiments. a Data taken from Ref. 10.
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ATP Synthesis Activity. E. coli biotin carboxylase is known to catalyze the formation of
ATP from ADP and carbamyl phosphate, as shown in Scheme 3.3.

MgADP + Carbamyl phosphate

MgATP + Carbamate

Scheme 3.3
The carbamate molecule rapidly decomposes to carbon dioxide and ammonia. This reaction
mimics the reverse of the physiological reaction, with carbamyl phosphate acting as a
carboxyphosphate analog. Note that the ATP synthesis reaction does not include biotin,
although biotin does stimulate the rate of ADP phosphorylation (8). The three mutations do not
appear to have markedly altered the kinetics of the ATP synthesis reaction (Table 3.5). The only
dissimilarity to wild type kinetics was exhibited by the two Arg 338 mutants. R338S had a Vmax
reduced by 2-fold and a Km ADP increased by two-fold. R338Q displayed a three-fold increase
in Km ADP, and two-fold decrease in Km CbmP, and a 5-fold increase in Vmax.
The degree of stimulation of the phosphoryl transfer by biotin was also compared for wild type
and the three mutants. The rate of ATP synthesis was examined with and without 60 mM biotin
(Table 3.6). Compared to wild type, the stimulation factor was slightly reduced for R338S and
R338Q (two-fold or less) and increased by two-fold for M169K.
Effect of Temperature on Activity. Clearly, it seems that the diseases caused by the three
homologous mutations of human biotin-dependent carboxylases are attributable, at least in part,
to their decreased activity. The impaired Vmax of the biotin-dependent ATPase reaction by the
homologous biotin carboxylase mutants corroborates this notion. However, since the assays on
the biotin carboxylase mutants were carried out at 25o C, denaturation of the protein structure at
body temperature (37o C) could not be ruled out. Thus, the biotin-dependent ATPase reaction
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Table 3.5. Kinetic Parameters for the ATP Synthesis Reaction

WTa
R338Q
R338S
M169K

Km CbmP

Km ADP

(mM)

(mM)

(min-1)

Vmax

4.8 ± 0.2
2.4 ± 0.2
6.9 ± 0.9
3.6 ± 0.6

0.19 ± 0.01
0.65 ± 0.05
0.39 ± 0.04
0.14 ± 0.01

0.31 ± 0.01
1.47 ± 0.04
0.14 ± 0.01
0.22 ± 0.01

The kinetic parameters were determined by varying [CbmP] at constant saturating levels
of ADP or by varying [ADP] at constant saturating levels of CbmP. The standard errors
on Km and Vmax were determined by nonlinear regression analysis. a Data taken from
Ref. 9.
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Table 3.6. Stimulation of ATP Synthesis by Biotin

WTa
R338Q
R338S
M169K

Stimulation Factor
25
18
12
53

The initial velocity of the ATP synthesis reaction was measured both in the presence and
absence of 60 mM biotin. All reactions contained saturating levels of CbmP, ADP, and
magnesium. The stimulation factor is the ratio of the rate with biotin to the rate without
biotin. a Data taken from Ref. 10.
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was carried out at 37o C for R338Q, R338S, and M169K. Compared to the data collected at 25o
C, the Vmax at 37oC was two-fold higher for both wild type and R338Q. R338S displayed a
three-fold increase in Vmax at 37o C, while M169K displayed a seven-fold increase.
Since the activity of the three mutants increased at 37oC, it can be surmised that the
overall protein structure was not damaged by the physiological temperature, and that the kinetics
observed for the mutants are representative of those in vivo. This assertion is further confirmed
by Western blot analysis of fibroblast extracts from patients carrying the mutations M204K and
R385S. Biotin carboxylase subunits of propionyl-CoA carboxylase were detected in the patient
fibroblasts with the M204K mutation (14). Biotin carboxylase subunits of 3-methylcrotonylCoA carboxylase were also detected in patient fibroblasts carrying the R385S mutation (6). The
presence of these proteins also argues against any intrinsic instability and subsequent degradation
of the enzyme due to the mutations.
Discussion
In this report, we used naturally occurring mutations of biotin-dependent carboxylases to
identify active site residues of E. coli biotin carboxylase for mutational analysis. The fact that
these mutations result in metabolic diseases in humans suggests that the homologous mutants in
E. coli biotin carboxylase will have altered kinetics that provide insight into the mechanism of
the enzyme as well as determine the molecular basis of the diseases. Indeed, these naturally
occurring mutants revealed two important observations concerning the mechanism of catalysis.
The most striking result was that all three mutants of E. coli biotin carboxylase exhibited
negative cooperativity with respect to the substrate bicarbonate. This is the first evidence that
one of the natural substrates exhibits cooperative behavior in E. coli biotin carboxylase and
substantiates previous work suggesting that the two subunits communicate (8, 17). The first
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evidence for communication between the two subunits of E. coli biotin carboxylase was that an
active site mutant, N290A, exhibited negative cooperativity with respect to carbamyl phosphate
in a slow non-physiological reaction where the phosphate group is transferred to ADP to make
ATP (8). Interestingly, carbamyl phosphate is an analog of the reaction intermediate
carboxyphosphate, which is the phosphorylated form of bicarbonate. A more compelling case
for communication between the subunits involved making hybrid dimers of biotin carboxylase
where one subunit had a wild-type active site while the other subunit contained an active site
mutation known to significantly decrease the activity of the enzyme (17). The active sites of the
enzyme are not at the interface between the two subunits (12). That is, the active sites are not
composed of residues from both subunits (also referred to as a shared active site). Kinetic
analyses of four hybrid dimers had Vmax values that were 0.4 to 3.6% of the Vmax value for
dimers composed of two wild type subunits. Thus, the two subunits of biotin carboxylase do not
function independently. If the two subunits acted independently, the Vmax values of the hybrids
would have been about half of the Vmax of the wild type enzyme. All four mutations exhibited a
dominant negative effect on the function of the wild type active site, suggesting there is
communication between the subunits. The observation of negative cooperativity in the N290A,
R338S, R338Q, and M169K mutants is consistent with the notion of communication between the
subunits and substantiates the possibility that the binding of substrate to one subunit affects the
kinetics of the other subunit.
The fact that a point mutation results in cooperative behavior suggests that multisubunit
proteins are teetering between cooperative and noncooperative behavior. There are numerous
examples of single amino acid substitutions bestowing cooperativity or abolishing cooperativity
in proteins. Examples are found in hemoglobin (1), aspartate transcarbamylase (18), pyruvate
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kinase (19) and the aspartate receptor (20). Given the precarious balance between cooperative
and noncooperative behavior, is the negative cooperativity observed here simply an artifact of
the mutations or does it provide any insight into the function of the enzyme? It is tempting to
speculate that the mutant forms of biotin carboxylase that exhibit negative cooperativity
represent evolutionary relics. This notion is supported by noting that the composition of the
early atmosphere contained high levels of carbon dioxide (21). Negative cooperativity was
detected only with respect to bicarbonate, not ATP or biotin. Negative cooperativity with respect
to bicarbonate could have conferred an evolutionary advantage to the organism by decreasing the
sensitivity of the enzyme to bicarbonate concentration. This would allow the enzyme to be
active over a broader range of bicarbonate concentrations than would be allowed by MichaelisMenten kinetics (22). As the level of CO2 in the environment stabilized, negative cooperativity
of biotin carboxylase would have ceased to confer any advantage for the organism. Thus the
gene coding for the enzyme would mutate to create an enzyme obeying Michaelis-Menten
kinetics.
In addition to negative cooperativity, the two Arg 338 mutants (R338Q and R338S)
revealed that arginine plays a significant role in carboxyl transfer to biotin. The 3:1 ratio of ADP
produced to carboxybiotin produced indicates that cleavage of ATP is uncoupled from carboxyl
transfer to biotin. What function could Arg 338 serve in the chemistry of carboxyl transfer? One
possibility would be to abstract the N1’ proton from biotin to allow for carboxylation. However,
finding an active site residue that acts as a catalytic base in biotin carboxylase has been
unsuccessful to date despite the mutation of ten active site amino acids. Furthermore, there is
virtually no precedent for an arginine acting as a general base in enzymic reactions. An alternate
explanation of the role of Arg 338 begins with the work of Levert et al. who implicated Lys 238
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as an essential residue in the production of carboxybiotin (9). Like the Arg 338 mutants,
mutation of Lys 238 resulted in uncoupling of ATP hydrolysis and biotin carboxylation. It is
interesting to note that of all the site-directed mutants of biotin carboxylase that have been
characterized, only mutations of Lys 238 and Arg 338 have resulted in uncoupling of ATP
hydrolysis and biotin carboxylation. Lys 238 acting as a catalytic base was ruled out because the
pKa value was found to be greater than 9.5. The Km for ATP for K238Q was 50-fold higher than
that of wild type, while the Km for ADP was only 5-fold higher. Similarly, R338Q and R338S
displayed a 50-fold increase in the Km for ATP along with a modest 3-fold increase in the Km for
ADP. Given the similarity in kinetics between K238Q and the two Arg 338 mutants, it is likely
that their catalytic roles are similar. Since Levert et al. concluded that Lys 238 interacted with
the gamma phosphate of ATP, it may be inferred that Arg 338 also interacts with the gamma
phosphate. Levert et al. went on to conclude that if Lys 238 binds to the gamma phosphate
group of ATP and in turn binds the phosphate group of carboxyphosphate, then Lys 238 may
help orient the phosphate group to act as a base for extraction of the proton from the 1’ nitrogen
of biotin. Thus, Arg 338 may act in concert with Lys 238 in the alignment of the phosphate
group of carboxyphosphate to carry out substrate-assisted catalysis, as illustrated in Figure 3.4.
Although this model seems inconsistent with the observation that the Km for CbmP (a
carboxyphosphate analog) for the two Arg 338 mutants was not significantly different than that
of wild type, it should be noted that CbmP is not the physiological substrate. In fact, the amide
nitrogen of CbmP can act as a hydrogen bond donor, whereas the carboxyl oxygen of
carboxyphosphate can act as a hydrogen bond acceptor. The fact that CbmP can have different
hydrogen bonding properties may cause it to be positioned differently than carboxyphosphate in
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the active site. Thus, although CbmP is an analog of a physiological intermediate, it may not
exactly mimic the binding of carboxyphosphate.
Does the kinetic analysis of the mutants found in patients with propionic acidemia and
methylcrotonylglycinuria correlate with the clinical phenotype? The patient with the mutation
M204K in propionyl-CoA carboxylase exhibited normal growth and development when treated
with a protein restricted diet (23). This mild clinical phenotype is consistent with the observation
that the overall function of the homologous mutation in E. coli biotin carboxylase (M169K) did
not severely cripple the enzyme. The mutant enzyme had a maximal velocity 10% of the wildtype value and exhibited negative cooperativity with respect to bicarbonate. However, all other
aspects of the kinetics of the M169K mutant were close to wild type, and most importantly, the
ratio of ADP to carboxybiotin production was 1:1. This is in contrast to the R338S mutant,
which showed a decreased production of carboxybiotin relative to ADP and a maximal velocity
that was 100-fold less than the wild type value. The fact that the R338S mutation resulted in a
defective E. coli biotin carboxylase is consistent with the severe phenotype exhibited by the
patient carrying the homologous mutation (R385S) in 3-methylcrotonyl-CoA carboxylase (6,
24). The clinical phenotype of the patient with the mutation (R374Q) in propionyl-CoA
carboxylase was not available.
It is important to note that although the M169K and R338S mutations both reduced the
Vmax, neither mutation completely abolished the carboxylation of biotin. Likewise, the residual
activity of the homologous mutant carboxylases in both patients was sufficient to allow
compensation for the deficiency through a modified diet (23, 24). By decreasing the flux of
metabolites through the amino acid catabolic pathway, the buildup of toxic intermediates can be
reduced. However, the severity of the two phenotypes was quite different, reflecting the
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importance of the individual roles of the two mutated residues. Despite the protein restricted
diet, the patient carrying the R385S mutation sustained irreversible brain damage and delayed
development. In contrast, the patient carrying the M204K mutation had normal growth and
development. Thus, the classical approach of studying naturally occurring, disease-causing
mutations in proteins allows genotype-phenotype correlations to be made.
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CHAPTER 4
CONCLUSIONS

The studies presented in this dissertation take advantage of the availability of 3dimensional structural information on E. coli biotin carboxylase, as well as the fact that the
enzyme is cloned, overexpressed and purified successfully. These features constitute an
excellent system for the construction and characterization of site-directed mutants. Ample
amounts of mutant protein can be obtained, ensuring unambiguous kinetic data, while structural
data can be used to aid kinetic interpretation. For these reasons, E. coli biotin carboxylase
provides an ideal model system for mechanistic studies applicable to all biotin-dependent
carboxylases.
In the first study, the question of how four highly conserved active site residues of biotin
carboxylase can play a role in catalysis was addressed. The residues Lys 116, Lys 159, His 209,
and Glu 276 were of interest because they were among the few residues with a high degree of
conservation in the ATP-grasp superfamily. Fortunately, crystal structures are available for
several enzymes of the superfamily, and the highly conserved residues can be visualized along
with their putative interactions with bound substrate (or substrate analogs). In this way, specific
roles for the homologous residues in E. coli biotin carboxylase can be inferred. By examining
the crystal structures of D-ala D-ala ligase, glutathione synthetase, carbamyl phosphate
synthetase, glycinamide ribonucleotide transformylase, and N5-carboxyaminoimidazole
ribonucleotide transformylase, the four residues were all postulated to be involved in contacts
with various moieties of the substrate ATP. Later however, when the crystal structure of biotin
carboxylase was solved with ATP in the active site, the postulated interactions by Lys 159, His
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209, and Glu 276 were brought into question; they were not consistent with the interactions
suggested by other ATP-grasp enzymes. However, in light of the fact that the crystallized
protein contained a mutation of an essential active site residue (to prevent hydrolysis of the ATP
ligand), the discrepancies may have been artifactual. To verify this possibility, and to explore
the roles of the four residues in the active site of biotin carboxylase, the mutations K116Q,
K159Q, H209A, and E276Q were constructed and analyzed by steady-state kinetics. Not
surprisingly, the Km values for ATP for all four mutants were elevated 40- to 90-fold relative to
wild type. This suggests that the four residues are indeed involved in binding ATP. As such, the
liganded crystal structure of the mutant biotin carboxylase proved not to be perfectly
representative of the wild type enzyme.
Another conspicuous difference between the mutant and wild type kinetics was that the
Vmax for the biotin-dependent ATPase activity was reduced between 30- and 260-fold. This
suggests that the four residues have significantly reduced substrate-induced synergism by biotin,
a perturbation caused by misalignment of ATP in the active site. In the wild type enzyme, the
binding of biotin causes ATP to bind more productively in the active site and an increase in Vmax
(i.e., substrate-induced synergism) is observed. On the other hand, a mutation of an important
residue might lead to a shift in the active site geometry that increases the number of
nonproductive binding modes of ATP. This manifests as a reduced rate of catalysis (i.e., no
substrate synergism).
In the second site-directed mutagenesis study, three mutations were selected for study
based on the fact that the homologous mutation in human propionyl-CoA carboxylase or 3methylcrotonyl-CoA carboxylase causes a metabolic disease resulting from deficient amino acid
catabolism. The mutations M204K and R374Q of human propionyl-CoA carboxylase cause
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propionic acidemia, while R385S of human 3-methylcrotonyl-CoA carboxylase causes
methylcrotonylglycinuria. The corresponding mutants in E. coli biotin carboxylase are M169K,
R338Q, and R338S.
Examination of the kinetics of these three mutants revealed that the production of ADP
and carboxybiotin was not stoichiometric in R338Q and R338S. The ratio of ATP to
carboxybiotin was approximately 3:1 for both mutants, suggesting sluggish production of
carboxybiotin. To date, only one other residue in biotin carboxylase, Lys 238, has been proven
to play a role in the stoichiometry of the biotin-dependent ATPase reaction. Thus it was
postulated that, since neither residue is likely to act as a catalytic base to deprotonate biotin, both
residues may be involved in positioning the carboxyphosphate intermediate for optimal carboxyl
transfer. This model is consistent with the fact that the Km for ATP for K238Q, R338Q, and
R338S, was elevated but the Km for ADP was not. These results imply an interaction with the γphosphate of ATP, which contributes to the carboxyphosphate intermediate.
The most intriguing kinetic result, and one which was obtained for all three mutants, was
the observation of negative cooperativity with respect to bicarbonate. The fact that negatively
cooperative kinetics is observed in a naturally-occurring mutant may not be purely coincidental.
There are several other known examples of single amino acid substitutions giving rise to
cooperative behavior. Furthermore, it seems likely that the mutations in this study represent
evolutionary relics. It has been speculated that there were high levels of CO2 in the prebiotic
atmosphere, which would imply high concentrations (and perhaps large fluctuations) of
bicarbonate in solution. Thus, an enzyme responsive to a broad range of substrate
concentrations, which could be accomplished by negatively cooperative kinetics, could be
beneficial to an organism.
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With respect to the diseases, the kinetic data correlates with the known phenotypes of the
patients carrying the homologous mutation. The phenotype of the patient carrying the R385S
mutation was severe, early onset neurological involvement with severe developmental delay.
This is presumably due to a low level of residual activity of 3-methylcrotonyl-CoA carboxylase,
which is in good agreement with the drastically (100-fold) reduced Vmax of the biotin-dependent
ATPase activity and the sluggish carboxylation of biotin exhibited by the R338S mutant of biotin
carboxylase. On the other hand, the Vmax for M169K was reduced by only 10-fold, implying a
higher level of residual activity in vivo. Indeed, the phenotype of the patient carrying the M204K
mutation was mild; normal growth and development was achieved in response to a proteinrestricted diet.
The use of the well-established E. coli biotin carboxylase model system in the two studies
of this dissertation have contributed significantly to our understanding of the catalytic
mechanism of biotin carboxylase. In both studies, the data obtained from the structural and
kinetic study of biotin carboxylase was shown to be applicable to other ATP-grasp enzymes
(including the other biotin-dependent carboxylases), and vice versa. Furthermore, the kinetic
examination of naturally-occurring, disease-causing mutations allows a molecular basis for
disease to be established.
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